Logo
x

Search

Subscribe Now

Candidate

GSK and Medicago Initiate P-III Trial for Adjuvanted COVID-19 Vaccine Candidate

GSK and Medicago Initiate P-III Trial for Adjuvanted COVID-19 Vaccine Candidate

  • March 17, 2021
Takeda Reports NDA Submission to Import and Distribute Moderna's mRNA-1273 in Japan

Takeda Reports NDA Submission to Import and Distribute Moderna's mRNA-1273 in Japan

  • March 5, 2021
Covaxx Initiates P-II Trial of UB-612 Against COVID-19 in Taiwan

Covaxx Initiates P-II Trial of UB-612 Against COVID-19 in Taiwan

  • February 3, 2021
Clover and Dynavax Plan to Initiate P-II/III Trial for Adjuvanted COVID-19 Vaccine Candidate

Clover and Dynavax Plan to Initiate P-II/III Trial for Adjuvanted COVID-19 Vaccine Candidate

  • February 2, 2021
Lilly Signs a License Agreement with Asahi Kasei Pharma for AK1780 to Treat Chronic Pain

Lilly Signs a License Agreement with Asahi Kasei Pharma for AK1780 to Treat Chronic Pain

  • January 29, 2021
J&J and US Government Amends their Agreement for the Next Phase of COVID-19 Vaccine Development

J&J and US Government Amends their Agreement for the Next Phase of COVID-19 Vaccine Development

  • November 16, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.